A morphological subset of circulating tumor cells in advanced prostate cancer reveals a potential biomarker for clinical outcomes.

Jasmine J. Wang,Karen A. Cavassani,Pai-Chi Teng,Jie-Fu Chen,Yu Jen Jan,Gina Chia-Yi Chu,Yi-Te Lee,Allen C. Gao,Dolores Di Vizio,Leland W.K. Chung,Sungyong You,Yazhen Zhu,Michael R. Freeman,Andre Rogatko,Ju Dong Yang,Hsian-Rong Tseng,Edwin M. Posadas

A morphological subset of circulating tumor cells in advanced prostate cancer reveals a potential biomarker for clinical outcomes.

2021

Jasmine J. Wang
Karen A. Cavassani
Pai-Chi Teng
Jie-Fu Chen
Yu Jen Jan
Gina Chia-Yi Chu
Yi-Te Lee
Allen C. Gao
Dolores Di Vizio
Leland W.K. Chung
Sungyong You
Yazhen Zhu
Michael R. Freeman
Andre Rogatko
Ju Dong Yang
Hsian-Rong Tseng
Edwin M. Posadas

e17008Background: A morphological subset of prostate cancer (PCa) circulating tumor cells (CTCs) with particularly small nuclei (< 8.5 μm), named very-small-nuclear CTCs (vsnCTCs), were found to be...

Keywords:

Medicine
Circulating tumor cell
potential biomarkers
Cancer research
Prostate cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations